Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 14 studies | 52% ± 21% | |
| oligodendrocyte | 12 studies | 35% ± 17% | |
| astrocyte | 11 studies | 29% ± 14% | |
| B cell | 9 studies | 22% ± 7% | |
| GABAergic neuron | 5 studies | 24% ± 6% | |
| naive B cell | 5 studies | 21% ± 3% | |
| endothelial cell | 4 studies | 26% ± 12% | |
| interneuron | 4 studies | 25% ± 12% | |
| neuron | 4 studies | 29% ± 11% | |
| epithelial cell | 4 studies | 25% ± 6% | |
| brush cell | 4 studies | 39% ± 10% | |
| renal principal cell | 4 studies | 25% ± 4% | |
| precursor B cell | 3 studies | 26% ± 2% | |
| immature B cell | 3 studies | 26% ± 5% | |
| glutamatergic neuron | 3 studies | 34% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 29% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 7814.83 | 328 / 328 | 100% | 44.00 | 178 / 178 |
| thymus | 100% | 6472.80 | 652 / 653 | 100% | 34.95 | 602 / 605 |
| kidney | 100% | 10627.78 | 89 / 89 | 99% | 45.34 | 892 / 901 |
| brain | 100% | 10026.39 | 2641 / 2642 | 99% | 117.57 | 695 / 705 |
| prostate | 99% | 5992.40 | 243 / 245 | 99% | 28.71 | 498 / 502 |
| breast | 100% | 6432.21 | 459 / 459 | 97% | 26.65 | 1087 / 1118 |
| liver | 100% | 3419.29 | 226 / 226 | 96% | 29.94 | 390 / 406 |
| lung | 98% | 4278.39 | 569 / 578 | 97% | 28.12 | 1120 / 1155 |
| esophagus | 91% | 2764.99 | 1317 / 1445 | 100% | 38.09 | 183 / 183 |
| uterus | 95% | 2633.93 | 162 / 170 | 95% | 29.46 | 436 / 459 |
| stomach | 88% | 12760.76 | 316 / 359 | 99% | 36.36 | 283 / 286 |
| bladder | 86% | 2894.62 | 18 / 21 | 98% | 37.60 | 494 / 504 |
| skin | 90% | 9471.22 | 1631 / 1809 | 86% | 20.11 | 404 / 472 |
| intestine | 69% | 4062.26 | 669 / 966 | 99% | 36.24 | 521 / 527 |
| adrenal gland | 100% | 5546.82 | 258 / 258 | 58% | 11.61 | 134 / 230 |
| ovary | 58% | 1061.31 | 104 / 180 | 73% | 11.87 | 312 / 430 |
| spleen | 100% | 5614.78 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 29.10 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 24.89 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 99% | 28.17 | 79 / 80 |
| adipose | 99% | 4621.74 | 1187 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 22.58 | 26 / 29 |
| heart | 89% | 2796.17 | 770 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 82% | 3433.78 | 1092 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 46% | 1214.59 | 427 / 929 | 0% | 0 | 0 / 0 |
| muscle | 27% | 474.99 | 216 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0034316 | Biological process | negative regulation of Arp2/3 complex-mediated actin nucleation |
| GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO_0099173 | Biological process | postsynapse organization |
| GO_0030837 | Biological process | negative regulation of actin filament polymerization |
| GO_1905445 | Biological process | positive regulation of clathrin coat assembly |
| GO_1901030 | Biological process | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| GO_0006897 | Biological process | endocytosis |
| GO_0006898 | Biological process | receptor-mediated endocytosis |
| GO_0032092 | Biological process | positive regulation of protein binding |
| GO_0060453 | Biological process | regulation of gastric acid secretion |
| GO_2000369 | Biological process | regulation of clathrin-dependent endocytosis |
| GO_0055123 | Biological process | digestive system development |
| GO_0045742 | Biological process | positive regulation of epidermal growth factor receptor signaling pathway |
| GO_0048268 | Biological process | clathrin coat assembly |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0050821 | Biological process | protein stabilization |
| GO_0007015 | Biological process | actin filament organization |
| GO_0030100 | Biological process | regulation of endocytosis |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
| GO_2000588 | Biological process | positive regulation of platelet-derived growth factor receptor-beta signaling pathway |
| GO_0032587 | Cellular component | ruffle membrane |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0043197 | Cellular component | dendritic spine |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0097060 | Cellular component | synaptic membrane |
| GO_0030136 | Cellular component | clathrin-coated vesicle |
| GO_0030864 | Cellular component | cortical actin cytoskeleton |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0005829 | Cellular component | cytosol |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005905 | Cellular component | clathrin-coated pit |
| GO_0032839 | Cellular component | dendrite cytoplasm |
| GO_0030665 | Cellular component | clathrin-coated vesicle membrane |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
| GO_0032051 | Molecular function | clathrin light chain binding |
| GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
| GO_0051015 | Molecular function | actin filament binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0035091 | Molecular function | phosphatidylinositol binding |
| GO_0035615 | Molecular function | clathrin adaptor activity |
| GO_0030276 | Molecular function | clathrin binding |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0080025 | Molecular function | phosphatidylinositol-3,5-bisphosphate binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0043325 | Molecular function | phosphatidylinositol-3,4-bisphosphate binding |
| GO_0017124 | Molecular function | SH3 domain binding |
| Gene name | HIP1R |
| Protein name | Huntingtin-interacting protein 1-related protein (HIP1-related protein) (Huntingtin-interacting protein 12) (HIP-12) Huntingtin interacting protein 1 related |
| Synonyms | HIP12 KIAA0655 |
| Description | FUNCTION: Component of clathrin-coated pits and vesicles, that may link the endocytic machinery to the actin cytoskeleton. Binds 3-phosphoinositides (via ENTH domain). May act through the ENTH domain to promote cell survival by stabilizing receptor tyrosine kinases following ligand-induced endocytosis. . |
| Accessions | ENST00000535012.1 H0YH66 O75146 ENST00000253083.9 [O75146-1] |